Pseudomonas aeruginosa is a key player in the pathology and morbidity of cystic fibrosis. Chronic obstructive pulmonary disease, which results from the most common and severe mutations in this genetic disorder, typically includes chronic infection with P. aeruginosa which, even with rugged antibiotic and physical therapy regimens, is rarely eradicated. It is not known whether the increased oligosaccharide sulfation characteristic of cystic fibrosis tracheobronchial mucins plays a role in the survival of P. aeruginosa in the airway. In this study, sulfated monosaccharides were synthesized and tested for their effects on the growth of clinical isolates and laboratory strains of this organism when supplied as the sole carbon source in vitro. Carbohydrate sulfation was observed to reduce, but not prohibit, growth of P. aeruginosa on carbohydrates normally utilized in their nonsulfated form. The various sulfated sugars employed as the sole carbon source gave characteristic and consistent growth profiles and maximum growth values across the strains tested. P. aeruginosa isolates from patients with cystic fibrosis often express a mucoid phenotype, which is thought to contribute to their ability to survive in harsh conditions. Carbohydrate sulfation effects on growth did not differ significantly between mucoid and nonmucoid strains. These results suggest that the additional sulfation of tracheobronchial mucin documented in cystic fibrosis may in fact contribute to the mucin’s resistance to utilization by P. aeruginosa and potentially other pathogens, providing an additional level of host protection, and limiting the available nutrient pool and thereby bacterial growth.
BallD. H.1966; Preparation and some reactions of monoethylidene derivatives of d-galactose, methyl α- and β-d-galactopyranosides, and of d-threose. J Org Chem 31:220–223[CrossRef]
BoatT. F., ChengP. W., IyerR. N., CarlsonD. M., PolonyI.1976; Human respiratory tract secretions. Mucous glycoproteins of nonpurulent tracheobronchial secretions, and sputum of patients with bronchitis and cystic fibrosis. Arch Biochem Biophys 177:95–104[CrossRef]
BuretA., CrippsA. W.1993; The immunoevasive activities of Pseudomonas aeruginosa. Relevance for cystic fibrosis. Am Rev Respir Dis 148:793–805[CrossRef]
ChaceK. C., LeahyD. S., MartinR., CarubelliR., FluxM., SachdevG. P.1983; Respiratory mucous secretions in patients with cystic fibrosis: relationship between levels of highly sulfated mucin component and severity of the disease. Clinica Chimica Acta 132:143–155[CrossRef]
ChanceD. L., MawhinneyT. P.1996; Disulfated oligosaccharides derived from tracheobronchial mucous glycoproteins of a patient suffering from cystic fibrosis. Carbohydr Res 295:157–177[CrossRef]
ChengP. W., BoatT. F., CranfillK., YankaskasJ. R., BoucherR. C.1989; Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis. J Clin Invest 84:68–72[CrossRef]
ClarkeP., SlaterJ. H.1986; Evolution of enzyme structure and function in Pseudomonas. In The Bacteria: A Treatise on Structure and Functionvol. XThe Biology of Pseudomonas pp. 71–143Edited bySokatchJ. R. New York: Academic Press;
CybulskiZ., MichalskaW., PietkiewiczK.1993; Epidemiological estimation of Pseudomonas aeruginosa strains isolated from different environments. Acta Microbiol Pol 42:259–65
DavrilM., DegrooteS., HumbertP., GalabertC., DumurV., LafitteJ.-J., LamblinG., RousselP.1999; The sialylation of bronchial mucins secreted by patients suffering from cystic fibrosis or from chronic bronchitis is related to the severity of airway infection. Glycobiology 9:311–321[CrossRef]
FitzgeraldJ. W., DodgsonK. S.1971a; Sulphur utilization during growth of Pseudomonas fluorescens on potassium d-glucose-6-O-sulfate. Biochem J 121:521–528
FitzgeraldJ. W., DodgsonK. S.1971b; Carbon and sulphur utilization during growth of Pseudomonas fluorescens on potassium d-glucose-6-O-sulfate as the sole sulphur source. Biochem J 122:277–283
JansenH. J., HartC. A., RhodesJ. M., SaundersJ. R., SmalleyJ. W.1999; A novel mucin-sulphatase activity found in Burkholderia cepacia and Pseudomonas aeruginosa. J Med Microbiol 48:551–557[CrossRef]
KonemanE. W., AllenS. D., JandaW. M., SchreckenbergerP. C., WinnW. C.Jr1992Color Atlas and Textbook of Diagnostic Microbiology, 4th edn. Philadelphia: J. B. Lippincott;
MawhinneyT. P., ChanceD. L.1994; Structural elucidation by fast atom bombardment mass spectrometry of multisulfated oligosaccharides isolated from human respiratory mucous glycoproteins. J Carbohydr Chem 13:825–840[CrossRef]
MawhinneyT. P., AdelsteinE., MorrisD. A., MawhinneyA. M., BarberoG. J.1987; Structure determination of five sulfated oligosaccharides derived from tracheobronchial mucus glycoprotein. J Biol Chem 262:2994–3001
MawhinneyT. P., AdelsteinE., GayerD. A., LandrumD. C., BarberoG. J.1992a; Structural analysis of monosulfated side-chain oligosaccharides isolated from human tracheobronchial mucous glycoproteins. Carbohydr Res 223:187–207[CrossRef]
MawhinneyT. P., LandrumD. C., GayerD. A., BarberoG. J.1992b; Sulfated sialyl-oligosaccharides derived from tracheobronchial mucous glycoproteins of a patient suffering from cystic fibrosis. Carbohydr Res 235:179–197[CrossRef]
NelsonJ. W., TredgettM. W., SheenhanJ. K., ThorntonD. J., NotmanD., GovanJ. R. W.1990; Mucinophilic and chemotactic properties of Pseudomonas aeruginosa in relation to pulmonary colonization with cystic fibrosis. Infect Immun 58:1489–1495
PrizontR., ReedW.1991; Differences in blood group B-specific mucinase activity between virulent and avirulent Shigella flexneri 2a strains. Microb Pathog 11:129–135[CrossRef]
ScharfmanA., Van BrusselE., HoudretN., LamblinG., RousselP.1996; Interactions between glycoconjugates from human respiratory airways and Pseudomonas aeruginosa. Am J Respir Crit Care Med 154:S163–169[CrossRef]
SmithA. W., ChahalB., FrenchG. L.1994; The human gastric pathogen Helicobacter pylori has a gene encoding an enzyme first classified as a mucinase in Vibrio cholerae. Mol Microbiol 13:153–160[CrossRef]
VieuJ. F., LepersJ. P., ChamoiseauG., BillonC., KleinB.1987; Epidemiology of Pseudomonas aeruginosa in Mauritania: study of 239 strains of various origins. Bull Soc Pathol Exot Filiales 80:771–780 (in French)
WhistlerR. L., SpencerW. W., BeMillerJ. N.1963; Sulfates, d-glucose 3-sulfate and 6-sulfate. In Methods in Carbohydrate Chemistryvol. IIReactions of Carbohydrates pp. 298–303Edited byWhistlerR. L., WolfromM. L. New York: Academic Press;
WiddicombeJ.1995; Relationships among the composition of mucus, epithelial lining liquid, and adhesion of microorganisms. Am J Respir Crit Care Med 151:2088–2093[CrossRef]